Young-Hee Lee Selected Research

terrein

10/2015	Terrein reduces age-related inflammation induced by oxidative stress through Nrf2/ERK1/2/HO-1 signalling in aged HDF cells.
12/2010	Enhancement of osteoblast biocompatibility on titanium surface with Terrein treatment.
4/2008	Terrein reduces pulpal inflammation in human dental pulp cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Young-Hee Lee Research Topics

Disease

16	Inflammation (Inflammations) 01/2018 - 04/2008
4	Drug-Related Side Effects and Adverse Reactions 12/2020 - 07/2011
4	Neoplasms (Cancer) 08/2017 - 03/2012
3	Rheumatoid Arthritis 03/2008 - 12/2006
2	Insulin Resistance 01/2019 - 09/2009
2	Diabetes Mellitus 01/2017 - 07/2013
2	Pain (Aches) 02/2015 - 06/2010
2	Fever (Fevers) 07/2011 - 06/2010
1	Experimental Melanoma 11/2021
1	Hypersensitivity (Allergy) 12/2019
1	Allergic Rhinitis 12/2019
1	Anaphylaxis (Anaphylactic Shock) 12/2019
1	Urticaria (Hives) 12/2019
1	Abdominal Pain (Pain, Abdominal) 12/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Hypotension (Low Blood Pressure) 03/2017
1	Peri-Implantitis 01/2017
1	Necrosis 10/2015
1	Bone Diseases (Bone Disease) 04/2015
1	Carcinoma (Carcinomatosis) 08/2014
1	Colonic Neoplasms (Colon Cancer) 08/2014
1	Hyperglycemia 07/2013
1	Alcoholic Neuropathy (Alcoholic Polyneuropathy) 07/2012
1	Hyperalgesia 07/2012
1	T-Cell Lymphoma (Lymphoma, T Cell) 03/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2012
1	Squamous Cell Carcinoma of Head and Neck 01/2012
1	Mouth Neoplasms (Oral Cancer) 01/2012
1	Coronary Disease (Coronary Heart Disease) 08/2011
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 07/2011
1	Eosinophilia 07/2011

Drug/Important Bio-Agent (IBA)

4	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2012 - 04/2008
4	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 04/2012 - 04/2008
3	AntioxidantsIBA 10/2015 - 04/2011
3	terreinIBA 10/2015 - 04/2008
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2015 - 04/2011
3	davallialactoneIBA 11/2013 - 04/2011
3	PPAR gammaIBA 10/2013 - 04/2009
3	GoldIBA 10/2013 - 01/2008
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 04/2015
2	Pharmaceutical PreparationsIBA 03/2017 - 03/2008
2	Dental Implants (Dental Implant)IBA 01/2017 - 04/2015
2	Interleukin-1beta (Interleukin 1 beta)IBA 10/2015 - 10/2013
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 10/2013 - 04/2011
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2013 - 04/2011
2	TitaniumIBA 10/2013 - 12/2010
2	Matrix Metalloproteinases (MMPs)IBA 04/2012 - 04/2009
2	AntigensIBA 03/2012 - 06/2009
2	Auranofin (Ridaura)FDA Link 03/2008 - 01/2008
1	Melanins (Melanin)IBA 11/2021
1	Chlorpheniramine (Chlorphenamine)FDA LinkGeneric 12/2019
1	Tryptases (Tryptase)IBA 12/2019
1	Histamine Antagonists (Antihistamines)IBA 12/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Imiquimod (Aldara)FDA LinkGeneric 01/2018
1	AntibodiesIBA 08/2017
1	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2017
1	Blood Substitutes (Artificial Blood)IBA 03/2017
1	propacetamolIBA 03/2017
1	Fentanyl (Sublimaze)FDA LinkGeneric 03/2017
1	AcidsIBA 03/2017
1	Interleukin-17 ReceptorsIBA 04/2015
1	CytokinesIBA 04/2015
1	Biocompatible Materials (Biomaterials)IBA 04/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2014
1	baccatin IIIIBA 08/2014
1	Glucose OxidaseIBA 11/2013
1	Complementary DNA (cDNA)IBA 10/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013
1	ChitosanIBA 10/2013
1	Glucose (Dextrose)FDA LinkGeneric 07/2013
1	CMW cement (Dentsply)IBA 04/2013
1	epoxy resin-based root canal sealerIBA 04/2013
1	pachymic acidIBA 04/2013
1	CPG-oligonucleotideIBA 02/2013
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2013
1	Epoxy Resins FDA Link 01/2013
1	Ethanol (Ethyl Alcohol)IBA 07/2012
1	RolipramIBA 07/2012
1	Phosphodiesterase 4 InhibitorsIBA 07/2012
1	VaccinesIBA 03/2012
1	LigandsIBA 03/2012
1	Galactosylceramides (Galactocerebrosides)IBA 03/2012
1	TriterpenesIBA 01/2012
1	fomitoside-KIBA 01/2012
1	GlycosidesIBA 01/2012
1	CholesterolIBA 08/2011
1	Oxidoreductases (Dehydrogenase)IBA 08/2011
1	Hypolipidemic Agents (Antihyperlipidemics)IBA 08/2011
1	CreatinineIBA 07/2011
1	Vancomycin FDA LinkGeneric 07/2011
1	LipopolysaccharidesIBA 04/2011
1	NF-kappa B (NF-kB)IBA 04/2011

Therapy/Procedure

3	Therapeutics 08/2017 - 06/2009
2	Oral Administration 08/2014 - 09/2009
1	Polypharmacy 12/2020
1	Immunotherapy 08/2017
1	Electrodes (Electrode) 02/2015
1	Intraperitoneal Injections 07/2012